Xiu-Wu Bian Selected Research

Therapeutics

4/2024	Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization.
10/2023	Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma.
1/2022	Anti-VEGFR2-labeled enzyme-immobilized metal-organic frameworks for tumor vasculature targeted catalytic therapy.
1/2022	SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling.
6/2021	Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.
1/2021	Metal-ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy.
12/2020	Pathological changes in the lungs and lymphatic organs of 12 COVID-19 autopsy cases.
11/2020	The role of lysosomes in cancer development and progression.
7/2020	Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.
1/2020	Triple-negative breast cancer molecular subtyping and treatment progress.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiu-Wu Bian Research Topics

Disease

84	Neoplasms (Cancer) 04/2024 - 10/2004
38	Glioma (Gliomas) 04/2024 - 10/2004
33	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 04/2006
19	Neoplasm Metastasis (Metastasis) 10/2023 - 12/2004
11	Carcinogenesis 03/2021 - 10/2004
9	COVID-19 03/2024 - 07/2020
8	Stomach Neoplasms (Stomach Cancer) 03/2021 - 01/2016
7	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2014
4	Hypoxia (Hypoxemia) 04/2024 - 08/2013
4	Medulloblastoma 01/2024 - 03/2012
4	Adenocarcinoma of Lung 01/2022 - 05/2013
4	Inflammation (Inflammations) 01/2021 - 03/2007
4	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 02/2012
3	Triple Negative Breast Neoplasms 01/2023 - 01/2020
3	Brain Neoplasms (Brain Tumor) 11/2022 - 03/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019 - 04/2013
3	Lymphatic Metastasis 10/2016 - 12/2004
3	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 12/2004
2	Liver Neoplasms (Liver Cancer) 10/2023 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
2	Muscle Cramp (Cramp) 01/2021 - 01/2018
2	Fibrosis (Cirrhosis) 01/2021 - 12/2020
2	Esophageal Squamous Cell Carcinoma 01/2020 - 04/2013
2	Ependymoma 01/2018 - 01/2016
2	Adenocarcinoma 04/2016 - 12/2004
2	Necrosis 01/2016 - 07/2012
2	Carcinoma (Carcinomatosis) 04/2012 - 12/2004
1	Bites and Stings (Sting) 01/2024

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2004
13	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2014
8	Messenger RNA (mRNA)IBA 02/2022 - 03/2007
8	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2016
7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2010
6	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2008
5	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2021
5	Temozolomide (Temodar)FDA LinkGeneric 02/2022 - 06/2017
5	LigandsIBA 01/2021 - 10/2004
5	nordyIBA 10/2017 - 04/2006
4	CateninsIBA 03/2021 - 05/2013
4	Masoprocol (Actinex)FDA Link 10/2017 - 04/2006
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 04/2006
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024 - 10/2022
3	UbiquitinIBA 10/2023 - 01/2017
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2017
3	EnzymesIBA 01/2022 - 08/2013
3	Connexin 43 (Connexin43)IBA 08/2018 - 02/2012
3	Aldehyde DehydrogenaseIBA 03/2018 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 03/2007
3	CollagenIBA 01/2017 - 06/2010
3	Peptides (Polypeptides)IBA 01/2016 - 04/2006
3	N-Formylmethionine Leucyl-PhenylalanineIBA 01/2008 - 04/2006
2	Eosine Yellowish-(YS) (Eosin)IBA 03/2024 - 12/2023
2	Hematoxylin (Haematoxylon)IBA 03/2024 - 12/2023
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2024 - 01/2022
2	Hydroxyl RadicalIBA 01/2024 - 01/2022
2	CytokinesIBA 12/2023 - 01/2022
2	MEF2 Transcription FactorsIBA 10/2023 - 03/2014
2	Programmed Cell Death 1 ReceptorIBA 10/2023 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 10/2023 - 01/2008
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2023 - 11/2017
2	Histones (Histone)IBA 09/2023 - 10/2019
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2023 - 01/2018
2	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 11/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 08/2016
2	HMGB1 Protein (HMG1)IBA 02/2022 - 11/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
2	IronIBA 01/2022 - 01/2022
2	ProteomeIBA 01/2022 - 06/2021
2	Disulfiram (Antabuse)FDA Link 01/2022 - 01/2017
2	MethyltransferasesIBA 01/2022 - 08/2016
2	Metal-Organic FrameworksIBA 01/2022 - 01/2018
2	CathelicidinsIBA 01/2021 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 10/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2016
2	TensinsIBA 01/2019 - 10/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 10/2016
2	Tamoxifen FDA LinkGeneric 03/2018 - 01/2014
2	ibrutinibIBA 01/2018 - 11/2017
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2017 - 05/2009
2	Cadherins (E-Cadherin)IBA 06/2016 - 02/2012
2	plerixafor FDA Link 04/2016 - 09/2015
2	Chemokine ReceptorsIBA 04/2016 - 09/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 07/2010
2	Chemotactic FactorsIBA 07/2010 - 03/2007
2	Vincristine (Oncovin)FDA LinkGeneric 06/2008 - 12/2007
1	dabrafenibIBA 04/2024
1	AdrenomedullinIBA 04/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024
1	Steroid Receptors (Steroid Receptor)IBA 03/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2024
1	manganese oxide (hausmannite)IBA 01/2024
1	hafnium oxideIBA 01/2024

Therapy/Procedure

36	Therapeutics 04/2024 - 05/2009
12	Drug Therapy (Chemotherapy) 01/2023 - 08/2016
8	Radiotherapy 01/2024 - 04/2013
8	Immunotherapy 01/2024 - 06/2011
3	Lasers (Laser) 01/2022 - 10/2004
1	Immunomodulation 01/2024